1. Home
  2. ACNB vs ALLO Comparison

ACNB vs ALLO Comparison

Compare ACNB & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACNB
  • ALLO
  • Stock Information
  • Founded
  • ACNB 1857
  • ALLO 2017
  • Country
  • ACNB United States
  • ALLO United States
  • Employees
  • ACNB N/A
  • ALLO N/A
  • Industry
  • ACNB Major Banks
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACNB Finance
  • ALLO Health Care
  • Exchange
  • ACNB Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • ACNB 450.1M
  • ALLO 363.1M
  • IPO Year
  • ACNB N/A
  • ALLO 2018
  • Fundamental
  • Price
  • ACNB $42.46
  • ALLO $1.29
  • Analyst Decision
  • ACNB Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • ACNB 4
  • ALLO 9
  • Target Price
  • ACNB $50.00
  • ALLO $8.44
  • AVG Volume (30 Days)
  • ACNB 20.4K
  • ALLO 3.6M
  • Earning Date
  • ACNB 07-24-2025
  • ALLO 08-06-2025
  • Dividend Yield
  • ACNB 3.19%
  • ALLO N/A
  • EPS Growth
  • ACNB N/A
  • ALLO N/A
  • EPS
  • ACNB 2.69
  • ALLO N/A
  • Revenue
  • ACNB $123,053,000.00
  • ALLO N/A
  • Revenue This Year
  • ACNB $38.67
  • ALLO N/A
  • Revenue Next Year
  • ACNB $5.26
  • ALLO $199.63
  • P/E Ratio
  • ACNB $15.83
  • ALLO N/A
  • Revenue Growth
  • ACNB 15.31
  • ALLO N/A
  • 52 Week Low
  • ACNB $35.37
  • ALLO $0.86
  • 52 Week High
  • ACNB $50.72
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • ACNB 46.07
  • ALLO 47.17
  • Support Level
  • ACNB $42.05
  • ALLO $1.21
  • Resistance Level
  • ACNB $44.05
  • ALLO $1.31
  • Average True Range (ATR)
  • ACNB 0.91
  • ALLO 0.11
  • MACD
  • ACNB -0.11
  • ALLO 0.01
  • Stochastic Oscillator
  • ACNB 20.50
  • ALLO 16.67

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: